Stock Information
Erasca, Inc. (ERAS)
Ticker Symbol: ERAS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,477.27 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.95
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -80.43%
Latest News
-
Erasca Throws Down A Gauntlet — And Revolution Throws It Right Back
Fri, Nov 20, 2026 9:16 PM
-
Erasca data add to pressure facing Revolution’s breakthrough cancer drug
Fri, Nov 20, 2026 5:18 PM
-
Sector Update: Healthcare Stocks Mixed Pre-Bell Friday
Fri, Nov 20, 2026 2:13 PM
-
Erasca falls 5% as early RAS cancer data leave key questions unanswered
Fri, Nov 20, 2026 1:16 PM
-
Erasca, Inc. (ERAS) Discusses Phase I Efficacy and Safety Data for Pan-RAS Molecular Glue ERAS-0015 Transcript
Fri, Nov 20, 2026 1:12 PM
-
Erasca Reports 44% Response Rate for ERAS-0015 in Advanced Pancreatic Cancer
Fri, Nov 20, 2026 12:38 PM
-
Erasca Reports Broad and Robust Phase 1 Clinical Efficacy and Favorable Safety Data for Pan-RAS Molecular Glue ERAS-0015
Fri, Nov 20, 2026 12:00 PM
-
Erasca Accelerates Pancreatic Cancer Study After Encouraging Monotherapy, Combination Results
Fri, Nov 20, 2026 11:40 AM
-
Erasca: 'Buy' On Expanded KRAS Targeting ERAS-4001 And Bristol-Myers Squibb Collaboration Tie-Up
Fri, Nov 20, 2026 10:53 AM
-
Bristol Myers Squibb (BMY) Is Pushing Deeper Into Neuroscience
Fri, Nov 20, 2026 8:11 AM
Key Financials
Financial data not available